Int J Med Sci 2021; 18(1):239-244. doi:10.7150/ijms.43100 This issue

Research Paper

Clinical Implications of HSC70 Expression in Clear Cell Renal Cell Carcinoma

Yixiao Zhang, Xudong Zhu, Xinbo Qiao, Lisha Sun, Tianhui Xia, Caigang Liu

Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, 110004, China.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Zhang Y, Zhu X, Qiao X, Sun L, Xia T, Liu C. Clinical Implications of HSC70 Expression in Clear Cell Renal Cell Carcinoma. Int J Med Sci 2021; 18(1):239-244. doi:10.7150/ijms.43100. Available from https://www.medsci.org/v18p0239.htm

File import instruction

Abstract

Purpose: The role of heat shock protein 70 (HSC70) in the progression of clear cell renal cell carcinoma (ccRCC) is unclear. This study explored the effect of the HSC70 on the survival of ccRCC patients.

Methods: Immunohistochemical analysis was performed to determine HSC70 expression in samples obtained from 121 ccRCC patients with at least 5 years of follow-up. We also analyzed the association between HSC70 expression and clinicopathological characteristics. Furthermore, the association of overall survival (OS) with HSC70 expression was analyzed using Kaplan-Meier curves. Finally, we used the Oncomine and CCLE databases to determine the effects of HSC70 mRNA expression on ccRCC.

Results: HSC70 expression was associated with distant metastasis and death of ccRCC patients. HSC70 was expressed in the nucleus and/or cytoplasm of ccRCC cells. The incidence of distant organ metastasis and death was higher in patients with HSC70 expression than in those without it. Survival analysis revealed that patients with HSC70 expression had significantly shorter OS. Oncomine analyses also showed that the HSC70 mRNA was significantly upregulated in ccRCC tissues.

Conclusions: HSC70 expression was related to adverse prognosis, and patients with HSC70 expression had a worse prognosis than those without HSC70 expression. HSC70 may thus serve as a potential therapeutic target for ccRCC.

Keywords: clear cell renal cell carcinoma, HSC70, prognosis